Homocysteine: Understanding the Lab Value

TL;DR: Homocysteine is an amino acid from methionine metabolism and a lab value. A value below 10 µmol/l is often classed as unremarkable, 10 to 15 as borderline, above 15 µmol/l as elevated. Elevated values are linked in observational studies with heart attack, stroke, thrombosis and dementia. Folate, B12 and B6 are involved in its breakdown. Whether and how an elevated value is treated is decided by a doctor.

This article is for information only and does not replace medical advice. Intake, dose and therapy of supplements or medications should be clarified with a doctor. With values above 15 µmol/l or symptoms, always speak to a doctor.

What Homocysteine Is

Homocysteine is a sulfur-containing amino acid. It forms when the body breaks down methionine from food. Methionine is found in meat, fish, eggs and dairy. Breakdown runs through an intermediate step: methionine becomes SAMe (S-adenosylmethionine), SAMe donates its methyl group and turns into SAH, SAH decays into homocysteine.

Homocysteine can accumulate, and it is then considered harmful to tissue. The body therefore has two routes to break it down again:

Remethylation. Homocysteine is converted back to methionine. This requires folate in its active form (5-MTHF) and B12 as a cofactor. Alternatively, the path runs via betaine and choline.

Transsulfuration. Homocysteine is broken down via cystathionine to cysteine and ultimately ends up in glutathione, an important antioxidant of the cell. This pathway needs vitamin B6 as a cofactor.

If one of these cofactors is missing, homocysteine piles up and the blood value rises. That is why homocysteine is regarded as an indicator of B vitamin supply and methylation capacity.

An example: a value of 13.5 µmol/l is in the borderline range. Anyone who documents it in Lab2go together with diet and other lab values can see how the value develops across several measurements and discuss the trend with a doctor.

Reference Ranges and Interpretation

The usual lab range is often below 15 µmol/l. From this value, hospitals speak of hyperhomocysteinemia. In the literature, lower values are also discussed as more favorable. The table below shows a commonly used classification.

Studies from the Framingham cohort and others found: every 5 µmol/l increase is associated with a roughly 20 percent higher risk of coronary heart disease and a 32 percent higher risk of stroke. That makes homocysteine a closely watched marker of cardiovascular risk. These are statistical associations, not a prediction for the individual case.

For the full picture of cardiovascular markers, see the guide on understanding blood values and on cholesterol values.

Risks of Elevated Homocysteine

Elevated homocysteine concentrations are linked with several conditions. The mechanisms described probably act at the same time.

Cardiovascular disease. Homocysteine is suspected of damaging the endothelium, the inner lining of blood vessels. It is also associated with oxidative stress and the oxidation of LDL cholesterol, which could promote accelerated atherosclerosis. Studies describe homocysteine above 10 µmol/l as an independent risk factor for heart attack and stroke, independent of cholesterol, blood pressure and smoking.

Cognitive decline and dementia. High homocysteine may disrupt methylation in the brain, which also plays a role in forming neurotransmitters like serotonin, dopamine and norepinephrine. A Framingham study found a doubled Alzheimer risk at values above 14 µmol/l compared with values below 10 µmol/l. The VITACOG trial examined B vitamin supplementation in elderly subjects with elevated homocysteine and reported slower brain atrophy in the intervention group. Whether a clinical benefit can be derived from this is still debated.

Thrombosis and clotting. Homocysteine activates platelets and affects the clotting cascade. Values above 15 µmol/l go along with an increased risk of deep vein thrombosis and pulmonary embolism. In thrombophilia workup, homocysteine is standard alongside Factor V Leiden and prothrombin mutation.

Other associations. Osteoporosis, early miscarriage (homocysteine affects placentation), neural tube defects in newborns and peripheral neuropathy have been described. The link to inflammation markers is also documented: high homocysteine correlates with elevated CRP.

The Methylation Cycle and MTHFR

To understand why some people have elevated values despite a balanced diet, it helps to look at the methylation cycle. The key enzyme is MTHFR, methylenetetrahydrofolate reductase.

MTHFR converts folate from food or synthetic folic acid into 5-MTHF, the active form. Only 5-MTHF can remethylate homocysteine back to methionine. If MTHFR activity is reduced, homocysteine can accumulate.

The polymorphisms. Two variants are common:

• C677T: The heterozygous form (one parent affected) reduces MTHFR activity by about 30 percent. The homozygous form (both parents) reduces it by 60 to 70 percent. In Central Europe, roughly 10 to 12 percent of the population carry the homozygous variant.
• A1298C: Weaker effect, reduces activity by 10 to 20 percent. Relevant mainly in combination with C677T.

Around 40 to 50 percent of the Central European population carry at least one variant. With elevated homocysteine and suspected MTHFR polymorphism, a doctor may consider a genetic test (cost roughly 50 to 150 euros).

Context. Folic acid first has to be activated by MTHFR, whereas methylfolate is already in its active form. Whether this difference matters in practice for people with a polymorphism is being studied. The evidence is limited. The choice of a folate form is a medical decision.

B Vitamins as Cofactors

Homocysteine breakdown depends on several micronutrients. With sufficient supply of all of them, the value usually lies in the unremarkable range.

Folate (vitamin B9). The most important cofactor for remethylation. In food, folate occurs as polyglutamate, which the small intestine breaks down to monoglutamate and absorbs. Supplements contain either folic acid (synthetic) or methylfolate (5-MTHF).

Vitamin B12 (cobalamin). Cofactor of methionine synthase, which converts homocysteine to methionine. B12 occurs in several forms: cyanocobalamin, methylcobalamin and hydroxocobalamin. With a vegan diet, the risk of B12 deficiency is higher, which should be checked by a doctor.

Vitamin B6 (pyridoxine). Cofactor of cystathionine synthase, which breaks down homocysteine via the transsulfuration pathway. Pyridoxal-5-phosphate (P5P) is the active form. EFSA has set a tolerable upper intake level for B6. Very high intake over a long time can cause peripheral neuropathy. For this reason, any additional B6 intake belongs under medical supervision.

Choline and betaine. Alternative remethylation pathway. Betaine (trimethylglycine, TMG) acts independently of folate and B12. Dietary sources of choline include egg yolk, liver and soybeans.

The effect of single cofactors cannot be viewed in isolation, because the metabolic pathways interlock. General background on supplements is in the supplement beginners guide. Any supplement should be discussed with a doctor beforehand, also because of possible interactions with medications.

Nutrition as a Foundation

Food delivers folate, B12, B6 and choline in natural form.

Folate-rich foods. Legumes lead the list, such as lentils and chickpeas. Leafy greens like spinach, kale and romaine are also good sources, as are broccoli, Brussels sprouts, beetroot, asparagus and avocado. Folate is sensitive to heat and light. Long cooking destroys up to 50 percent of it; steaming or brief sautéing preserves more.

B12 sources. B12 comes almost exclusively from animal products. Beef liver is particularly rich. Other sources are salmon, mackerel, herring, eggs, dairy, beef and pork. Plant sources like algae or fermented products are considered unreliable.

B6 sources. Poultry, salmon, bananas, potatoes, chickpeas, sunflower seeds. B6 is heat-sensitive; raw or gently cooked food preserves more.

Choline sources. Egg yolk, beef liver, soybeans, wheat germ, peanuts.

People who eat mostly plant-based can have their B12 status checked by a doctor. The lab measures B12 and, where appropriate, homocysteine.

Research and Medical Assessment

If homocysteine is above 10 µmol/l, the doctor first looks for possible causes. These include reduced kidney function, an underactive thyroid, B12 or folate deficiency, genetic factors and medications such as methotrexate or anticonvulsants.

What studies examine. Intervention studies test whether B vitamin intake changes the homocysteine value and whether this affects disease events. The results are inconsistent and the evidence is limited. The level of evidence for a clinical benefit of changing the value is therefore not conclusively settled.

Risks and interactions. High B6 intake over a long time can cause nerve damage. Certain medications affect folate metabolism or homocysteine levels. For this reason, self-experimentation with supplements is not advisable. Intake, the dose set by the doctor, and therapy belong in a doctor’s hands.

When medical assessment is needed. With values above 30 µmol/l, after thrombosis or stroke, and with symptoms, a doctor should be consulted promptly. For other micronutrients often mentioned in this context, such as vitamin D3+K2, the same applies: information does not replace medical judgment.

Testing Frequency and Measurement

Homocysteine is a meaningful marker, but sample processing must be correct. Faulty collection distorts the value significantly.

Fasting measurement. Standard is measurement after 8 to 12 hours without food. A protein-rich breakfast can raise the value by 1 to 3 µmol/l short term. Water is fine.

Sample processing. The sample must be centrifuged within 60 minutes and the plasma separated. Otherwise red blood cells keep releasing homocysteine and the value rises artificially. Labs differ in whether they use EDTA plasma or serum and how fast they centrifuge. With long shipping routes, homocysteine is particularly prone to error.

Testing frequency (common guidance):

• Healthy adults: every 2 to 3 years. A baseline is enough for orientation.
• With cardiovascular risk: annually. Especially with high blood pressure, diabetes, family history.
• With elevated values: follow-up as set by the doctor.
• With thrombosis tendency or after stroke: annually, in coordination with the doctor.

For systematic documentation of lab values, see the features of Lab2go.

Homocysteine in Context With Other Markers

Homocysteine does not stand alone. Three connections to other biomarkers are especially informative.

Homocysteine and lipids. Elevated homocysteine is associated with the oxidation of LDL cholesterol. Oxidized LDL accumulates in vessel walls and drives plaque formation. When LDL is high and homocysteine is elevated at the same time, cardiovascular risk is especially high. More on this in the guide on cholesterol values.

Homocysteine and inflammation. High homocysteine correlates with elevated CRP and interleukin-6. Both values together give hints of silent inflammation. Details in the guide on inflammation markers in blood.

Homocysteine and B12 status. When B12 is low, homocysteine typically rises before blood B12 drops. Homocysteine is therefore regarded as a sensitive early indicator of B12 deficiency, often before clinical symptoms appear. With borderline B12 (200 to 300 pmol/l), a doctor may additionally order holo-transcobalamin and methylmalonic acid.

Conclusion: Homocysteine in the Baseline Panel

Homocysteine provides information about methylation, B vitamin supply and cardiovascular risk and is often not included in routine lab testing. A value below 10 µmol/l is mostly classed as unremarkable; a value above 15 µmol/l should be checked by a doctor.

Three steps for orientation:

1. Establish a baseline. At the next blood draw, homocysteine can be measured fasting (cost: 25 to 40 euros). What matters is that the lab processes the sample correctly.
2. Have the value interpreted. Elevated values are assessed by a doctor together with B12, folate, kidney values and medications.
3. Track the trend. The doctor sets the follow-up dates. The results can be recorded clearly.

The baseline blood values guide is a good starting point. For documentation, see the features of Lab2go or the plans and pricing.

This article is for information only and does not replace medical advice. Intake, dose and therapy should be clarified with a doctor. With homocysteine above 30 µmol/l, after thrombosis or stroke, and with severe B12 deficiency, always consult a doctor. Self-tracking complements medicine. It does not replace it.